about
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcomeReceptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patientsSolitary fibrous tumour of thyroid: report of two cases with immunohistochemical features and literature review.Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancerEvaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade.US-guided application of Nd:YAG laser in porcine pancreatic tissue: an ex vivo study and numerical simulation.Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.Tumour proliferation, angiogenesis, and ploidy status in human colon cancerCOX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables.Deregulation of dicer and mir-155 expression in liposarcoma.In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas.Breast-like vulvar lesion with concurrent breast cancer: a case report and critical literature review.Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature.COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge.Recurrent scrotal hemangiomas during treatment with sunitinib.Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.PML down-regulation in soft tissue sarcomas.Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.Reply to 'Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma' (Am Surg 2012;78:225-9).Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases.Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid.Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice.Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report.Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation.Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease.Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.HER2 amplification status in gastric and gastro-oesophageal junction cancer in routine clinical practice: which sample should be used?Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLDCaveolin-1 expression in human breast lobular cancer progressionIntratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancerCOX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breastCOX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification
P50
Q28297992-CE7AF1FA-2329-4BBB-AD5B-D2F836F74FE4Q28740575-62E27818-96F0-45BA-91E6-A9C2C3C17869Q33594908-432C25D3-6294-4DE7-9FF7-A062BF1F9A73Q33644262-358B8098-2651-4A0B-93D5-40210B45343FQ33747550-CC493FBE-E5EE-4502-BDA1-9D0CF1353214Q33982331-0FFE6D73-C9ED-404D-8B63-2AEF15FE58E4Q34574793-CAF97040-73C2-48B2-B18E-63FE136BB004Q34726390-4A53B379-744B-438A-AC64-EF02779CDB1DQ35197256-E438527E-0E77-465F-B0B5-C85F56A09DF7Q35198312-B6D0C320-3547-45F9-9C67-FBAF152A4331Q35588810-7A49FAD6-A67B-4F9E-AAE5-2B7026545D9EQ35769624-864C5B5A-6175-4E34-B9E8-5E764171F2B6Q35833073-F64EC16C-4B9B-479A-9CD3-A7412BFE540DQ36232533-F5632B54-DE40-4DEA-BD83-9FF84ECC8DFBQ37536481-C84C3784-25EA-4BBC-9139-E0F55FB21779Q38256304-9B73D40C-FB4F-4B33-8ACD-ABC92B045CA7Q38443121-42F86390-ABB8-430B-BC8D-FD0BFF302E55Q42740878-62F88C15-020C-4188-9F0E-1231F15CACB6Q42914713-6015C9B3-EDAE-4F7F-9359-73110EFD81F8Q43082274-78F415E3-CB15-427D-B0C4-7F8B8BA45E24Q43191335-24057B94-01F8-40BB-BD87-A70FF4BA7178Q43469194-BB98BC51-8721-41CC-85DB-6757689CB006Q44105819-0D04609E-8AF7-4966-9CD2-F278EF38CA05Q44592250-E41BAFFA-228F-4726-A2D6-728DAFEDF660Q45148168-C1056057-BD6C-4660-8A06-B5931709CD6EQ45806342-15E7AF43-B8E4-45DE-9460-0CFFB743CFEBQ45814967-70628A7A-A09E-4022-8F5F-F7DA0DAA1D0FQ46235518-E8AE291C-139E-4FC7-A078-EC8267DA989AQ47606734-30BBCB04-95ED-4EB7-9620-48090C7691F8Q51979757-09EB6311-FE80-45A6-B50A-7AF558596986Q53248096-E02DA1E1-0F4C-497D-8507-24BD7B5D9F81Q53447872-53482258-E5B1-4155-8B21-05E72F067F16Q54333861-5086B8B4-539F-4CCD-99C3-7E65032E0864Q54487686-098A4A50-A875-4526-BE55-6A3751D72156Q54513642-A800DFEB-BEB0-4586-8BF1-782A8AEE0871Q56101182-C3713EF0-0131-46FD-AE53-3B394DCC2DB8Q56101210-2A7F3A8B-E80E-4689-ADC9-0F5901267C47Q56101218-338D8BA1-E9C7-43B8-8D4F-8034C29073E5Q56101229-6F930913-B789-4DA8-87B3-0A682DB09A2DQ56101234-D2EB3501-50D7-4706-90B6-85EB025B0286
P50
description
researcher ORCID ID = 0000-0002-9538-5729
@en
wetenschapper
@nl
name
Giuseppe Perrone
@ast
Giuseppe Perrone
@en
Giuseppe Perrone
@es
Giuseppe Perrone
@nl
type
label
Giuseppe Perrone
@ast
Giuseppe Perrone
@en
Giuseppe Perrone
@es
Giuseppe Perrone
@nl
prefLabel
Giuseppe Perrone
@ast
Giuseppe Perrone
@en
Giuseppe Perrone
@es
Giuseppe Perrone
@nl
P1153
7006216649
P21
P31
P496
0000-0002-9538-5729